Wockhardt Limited engages in the pharmaceutical business. Its products include formulations, biopharmaceuticals, nutrition products, vaccines and active pharmaceutical ingredients. The company was founded by Habil Fakhruddin Khorakiwala in 1967 and is headquartered in Mumbai, India.

wockhardt limited company operating in Health Technology Sector and dealing in Pharmaceuticals: Other. wockhardt limited is SEBI Listed Company (India) and having:-

ISIN (An International Securities Identification Number): INE049B01025
Equity Stock (National Stock Exchange) Symbol: WOCKPHARMA
NSE Link IS: https://www.nseindia.com/get-quotes/equity?symbol=WOCKPHARMA
BSE Link IS: https://www.bseindia.com/stock-share-price/wockhardt-ltd/WOCKPHARMA/532300/

Wockhardt is a Global Pharmaceutical and Biotech Company and is India’s leading research-based global healthcare enterprise with relevance in the fields of Pharmaceuticals, Biotechnology, and a chain of advanced Super Speciality Hospitals.[1]

Wockhardt is a global pharmaceutical and biotechnology organisation, providing affordable, high-quality medicines for a healthier world. It is India’s leading research-based global healthcare enterprise with relevance in the fields of Pharmaceuticals, Biotechnology and a chain of advanced Super Speciality Hospitals.

Wockhardt is a true Indian Multi-National Company with a multi-ethnic workforce of 8600 Wockhardt Associates from 21 different nationalities globally. It has 3 research centres and 12 manufacturing plants, with businesses ranging from the manufacture and marketing of Pharmaceutical and Bio-pharmaceutical formulations, Active Pharmaceutical Ingredients (APIs) and Vaccines.

Headquatered in Mumbai, India, Wockhardt has full-fledged operations in the USA, UK, Ireland and France. It also has its marketing presence in emerging markets of Russia, Brazil, Mexico, Vietnam, Philippines, Nigeria, Kenya, Ghana, Tanzania, Uganda, Nepal, Myanmar, Sri Lanka, Mauritius, Lebanon and Kuwait.

Wockhardt’s core business is innovation. It uses science and technology to develop medicines and other products that improve the quality of millions people’s lives through better health.

Wockhardt aspires to create a healthier world. Its strategic vision of ‘More & More with Less & Less’ has transformed into new ways of thinking, a new journey for growth, medical breakthroughs for patients and continuing value for all stakeholders.

Wockhardt Ltd. stand with []

Company Website: http://www.wockhardt.com/
Company Website2: http://www.wockhardt.com/
LinkedIn page URL: https://in.linkedin.com/company/wockhardt
Wiki Profile URL: https://en.wikipedia.org/wiki/Wockhardt

Popular Search Keywords: wockhardt limited , company management , company history , company profile , company information , business directory , Stock Market News , annual report , quarterly results , profit and loss , Koo Capital , KooCapital.Com , KooCapital News , Health Technology Sector Company , Pharmaceuticals: Other industry

#wockhardt #limited #company #management #company #history #company #profile #company #information #business #directory #stock #market #news #annual #report #quarterly #results #profit #and #loss #koo #capital #koocapital #com #koocapital #news #health #technology #sector #company #pharmaceuticals #other #industry

The post Wockhardt Limited – Company Profile – Company information | KooCapital.Com appeared first on KooCapital.Com.

Jagsonpal Pharmaceuticals Limited is a pharmaceutical company, which engages in the development and manufacture of intermediate drugs and pharmaceutical formulations. Its products include capsule, tablet, and ampoule. The company was founded by Jagmohan Singh Kochhar in 1964 and is headquartered in New Delhi, India.

jagsonpal pharmaceuticals limited company operating in Health Technology Sector and dealing in Pharmaceuticals: Other. jagsonpal pharmaceuticals limited is SEBI Listed Company (India) and having:-

ISIN (An International Securities Identification Number): INE048B01027
Equity Stock (National Stock Exchange) Symbol: JAGSNPHARM
NSE Link IS: https://www.nseindia.com/get-quotes/equity?symbol=JAGSNPHARM
BSE Link IS: https://www.bseindia.com/stock-share-price/jagsonpal-pharmaceuticals-ltd/JAGSNPHARM/507789/

Jagsonpal Pharmaceuticals is primarily engaged in the manufacturing and trading of pharmaceutical products and APIs. The Company has operations in India and caters to both domestic and international markets.

Jagsonpal is among India’s premier pharmaceutical companies. Jagsonpal has substantial research and development, manufacturing, marketing, and distribution facilities. An impeccable track record of growth and profitability spanning over 4 decades, makes Jagsonpal an ideal company to partner with. Founded in 1964 the company specializes in developing and manufacturing bulk drugs and pharmaceutical formulations. Over the past 50 years, the firm has grown by leaps and bounds. The firm is committed to sustainable growth and is aggressively pursuing growth through market penetration, market expansion, and multi-national expansion. The firm’s objective is to increase market share and become a dominant player in the Indian Pharmaceutical Industry. Jagsonpal has an expanding international portfolio of affiliates, joint ventures and representative offices across the globe making it a truly international operation. The firm is represented by 2,500 agents worldwide and has offices in 3 continents. The company’s operations span Russia, Brazil, USA, Ukraine, Sri Lanka, Cameroon, Thailand, Argentina, Germany, Switzerland, Korea, Egypt and Vietnam making Jagsonpal’s reach truly global.

Jagsonpal Pharmaceuticals Ltd. stand with [An influential science based patient-centric healthcare provider offering trustworthy products with exceptional quality]

Company Website: http://www.jagsonpal.com/
Company Website2: http://www.jagsonpal.com/
LinkedIn page URL: https://in.linkedin.com/company/jagsonpal-pharmaceuticals
Wiki Profile URL:

Popular Search Keywords: jagsonpal pharmaceuticals limited , company management , company history , company profile , company information , business directory , Stock Market News , annual report , quarterly results , profit and loss , Koo Capital , KooCapital.Com , KooCapital News , Health Technology Sector Company , Pharmaceuticals: Other industry

#jagsonpal #pharmaceuticals #limited #company #management #company #history #company #profile #company #information #business #directory #stock #market #news #annual #report #quarterly #results #profit #and #loss #koo #capital #koocapital #com #koocapital #news #health #technology #sector #company #pharmaceuticals #other #industry

The post Jagsonpal Pharmaceuticals Limited – Company Profile – Company information | KooCapital.Com appeared first on KooCapital.Com.

Nectar Lifesciences Limited is a holding company, which engages in the manufacture and distribution of pharmaceutical products. Its products include active pharmaceutical ingredients and intermediates; formulations; diagnostics; empty hard gelatin capsules; and menthol. The company was founded by Sanjiv Goyal on June 27, 1995 and is headquartered in Chandigarh, India.

nectar lifesciences limited company operating in Health Technology Sector and dealing in Pharmaceuticals: Other. nectar lifesciences limited is SEBI Listed Company (India) and having:-

ISIN (An International Securities Identification Number): INE023H01027
Equity Stock (National Stock Exchange) Symbol: NECLIFE
NSE Link IS: https://www.nseindia.com/get-quotes/equity?symbol=NECLIFE
BSE Link IS: https://www.bseindia.com/stock-share-price/nectar-lifescience-ltd/NECLIFE/532649/

Nectar Lifesciences a pharmaceutical company, primarily engages in the development, manufacture, and marketing of various active pharmaceutical ingredients (APIs) and finished dosage forms.

Nectar Lifesciences Ltd (NecLife) is a 300 million US$ integrated pharmaceutical organization, offering comprehensive range of Cephalosporin Active Pharmaceutical Ingredients and Finished Dosage Forms. The development and manufacture of quality intermediates, bulk actives have been critical to our success to become one of the largest manufacturers of cephalosporin range of products and delivering innovative and affordable products to domestic as well as international markets. NecLife has tactically positioned itself in the global pharmaceutical industry. It has developed sustainable production systems to manufacture highest quality pharmaceutical products meeting diverse requirements of its customer base in over 45 countries worldwide from its globally approved facilities. Other services and products manufactured by Nectar are:

CRAMS:NecLife is a preferred contract manufacturer for leading pharmaceutical companies providing a full range of services.

Hard Gelatin Capsules: NecLife manufactures two-piece double lock gelatin capsules in all sizes, with customized colours and printing.

In vitro Diagnostics: Nectar manufactures a range of rapid test kits, biochemistry, haematology and serology products in its ISO 13485 approved facility

Natural Products:

Menthol and mint derivatves: NecLife offers the best quality Menthol and Mint Derivatives consistently and has emerged as a major supplier globally. Winner of export award from government of India. First to file USDMF for natural menthol.

Guar Gum: NecLife manufactures highest viscosity guar gum powder for oil and gas, food and pharmaceutical industry.

Nectar Lifesciences Limited stand with []

Company Website: http://www.neclife.com/
Company Website2: http://www.neclife.com/
LinkedIn page URL: https://in.linkedin.com/company/nectar-life-science
Wiki Profile URL: https://en.wikipedia.org/wiki/Nectar_Lifesciences

Popular Search Keywords: nectar lifesciences limited , company management , company history , company profile , company information , business directory , Stock Market News , annual report , quarterly results , profit and loss , Koo Capital , KooCapital.Com , KooCapital News , Health Technology Sector Company , Pharmaceuticals: Other industry

#nectar #lifesciences #limited #company #management #company #history #company #profile #company #information #business #directory #stock #market #news #annual #report #quarterly #results #profit #and #loss #koo #capital #koocapital #com #koocapital #news #health #technology #sector #company #pharmaceuticals #other #industry

The post Nectar Lifesciences Limited Company Profile – KooCapital.Com | Stock Market News appeared first on KooCapital.Com.

Cipla Limited engages in the manufacture and distribution of healthcare products and bulk drugs. It operates through the following segments: Pharmaceuticals and New Ventures. The Pharmaceuticals segment develops, manufactures, sells and distributes generic or branded generic medicines as well as active pharmaceutical ingredients. The New Ventures segment includes the operations of the two wholly owned subsidiaries, Cipla Health Ltd., a consumer healthcare company and Cipla BioTec Pvt. Ltd, which is into the business of Biosimilars. The company was founded by Khwaja Abdul Hamied in 1935 and is headquartered in Mumbai, India.

cipla limited company operating in Health Technology Sector and dealing in Pharmaceuticals: Other. cipla limited is SEBI Listed Company (India) and having:-

ISIN (An International Securities Identification Number): INE059A01026
Equity Stock (National Stock Exchange) Symbol: CIPLA
NSE Link IS: https://www.nseindia.com/get-quotes/equity?symbol=CIPLA
BSE Link IS: https://www.bseindia.com/stock-share-price/cipla-ltd/CIPLA/500087/

Cipla is engaged in the Business of Pharmaceuticals.(Source : 202003 Annual Report Page No:157)

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients. For over 80 years, Cipla has emerged as one of the most respected pharmaceutical names in India as well as across more than 100 countries. Our portfolio includes over 1000 products across wide range of therapeutic categories with one quality standard globally.

Whilst delivering a long-term sustainable business, Cipla recognises its duty to provide affordable medicines. Cipla’s emphasis on access for patients was recognised globally for the pioneering role played in HIV/AIDS treatment as the first pharmaceutical company to provide a triple combination anti-retroviral (ARV) in Africa at less than a dollar a day and thereby treating many millions of patients since 2001.

Cipla’s research and development focuses on developing innovative products and drug delivery systems.

Cipla stand with []

Company Website: http://www.cipla.com/
Company Website2: http://www.cipla.com/
LinkedIn page URL: https://in.linkedin.com/company/cipla
Wiki Profile URL: https://en.wikipedia.org/wiki/Cipla

Popular Search Keywords: cipla limited , company management , company history , company profile , company information , business directory , Stock Market News , annual report , quarterly results , profit and loss , Koo Capital , KooCapital.Com , KooCapital News , Health Technology Sector Company , Pharmaceuticals: Other industry

#cipla #limited #company #management #company #history #company #profile #company #information #business #directory #stock #market #news #annual #report #quarterly #results #profit #and #loss #koo #capital #koocapital #com #koocapital #news #health #technology #sector #company #pharmaceuticals #other #industry

The post Cipla Limited Company Profile | KooCapital.Com appeared first on KooCapital.Com.

Alembic Pharmaceuticals Limited is a research and development pharmaceutical company. It is engaged in the research, development, manufacture, and market of generic and branded pharmaceutical products. The firm’s businesses are Active Pharmaceutical Ingredients and Formulations. It focuses on the following therapeutic areas: Dermatology, Cardiology, Anti-Diabetic, Gastrology, Ophthalmology, Nephrology and Urology, Anti-Infective, Oncology, and cold and cough. The company was founded in 1907 and is headquartered in Vadodara, India.

alembic pharmaceuticals limited company operating in Health Technology Sector and dealing in Pharmaceuticals: Other. alembic pharmaceuticals limited is SEBI Listed Company (India) and having:-

ISIN (An International Securities Identification Number): INE901L01018
Equity Stock (National Stock Exchange) Symbol: APLLTD
NSE Link IS: https://www.nseindia.com/get-quotes/equity?symbol=APLLTD
BSE Link IS: https://www.bseindia.com/stock-share-price/alembic-pharmaceuticals-ltd/APLLTD/533573/

Alembic Pharmaceuticals is in the business of development, manufacturing, and marketing of Pharmaceuticals products i.e. Formulations and Active Pharmaceutical Ingredients. The company has 3 R&D and 5 manufacturing facilities.

52% turnover from International Generics [1] Alembic Pharma operates through 3 primary business segments – International generics (52% of sales, with 75% being from the US), Domestic branded business (32% of sales), and API business(16% of sales) as of Q3FY21.

Established in 1907, Alembic Pharmaceuticals Limited is a leading pharmaceutical company in India. The Company is vertically integrated with the ability to develop, manufacture and market pharmaceutical products, pharmaceutical substances and Intermediates. Alembic is the market leader in the Macrolides segment of anti-infective drugs in India. Alembic’s manufacturing facilities are located in Vadodara and Baddi in Himachal Pradesh. The plant at Vadodara has the largest fermentation capacity in India. The Panelav facility houses the API and formulation manufacturing (both US FDA approved) plants. The plant at Baddi, Himachal Pradesh manufactures formulations for the domestic and non-regulated export market. The company has a state of the art Research Centre at Vadodara.

Alembic Pharmaceuticals Limited stand with []

Company Website: http://www.alembic-india.com/
Company Website2: http://www.alembic-india.com/
LinkedIn page URL: https://in.linkedin.com/company/alembic
Wiki Profile URL:

Popular Search Keywords: alembic pharmaceuticals limited , company management , company history , company profile , company information , business directory , Stock Market News , annual report , quarterly results , profit and loss , Koo Capital , KooCapital.Com , KooCapital News , Health Technology Sector Company , Pharmaceuticals: Other industry

#alembic #pharmaceuticals #limited #company #management #company #history #company #profile #company #information #business #directory #stock #market #news #annual #report #quarterly #results #profit #and #loss #koo #capital #koocapital #com #koocapital #news #health #technology #sector #company #pharmaceuticals #other #industry

The post Alembic Pharmaceuticals Limited – Company Profile – Company information | KooCapital.Com appeared first on KooCapital.Com.

Glenmark Pharmaceuticals Limited is a holding company, which engages in the development, manufacture and marketing of pharmaceutical products. It operates through the following geographical segments: India, North America, Latin America, Europe, and Rest of the World. The company was founded by Gracias Saldanha on November 18, 1977 and is headquartered in Mumbai, India.

glenmark pharmaceuticals limited company operating in Health Technology Sector and dealing in Pharmaceuticals: Other. glenmark pharmaceuticals limited is SEBI Listed Company (India) and having:-

ISIN (An International Securities Identification Number): INE935A01035
Equity Stock (National Stock Exchange) Symbol: GLENMARK
NSE Link IS: https://www.nseindia.com/get-quotes/equity?symbol=GLENMARK
BSE Link IS: https://www.bseindia.com/stock-share-price/glenmark-pharmaceuticals-ltd/GLENMARK/532296/

Glenmark Pharmaceuticals Ltd is a global research-led pharmaceutical company with presence across generics, Specialty and OTC business with operations in over 80 countries.[1]

Product Offerings The company offers a wide range of pharma products/ drugs in the form of oral solids, liquids, topical products, respiratory MDI/DPI and complex injectables & biologics. It is primarily focused on therapy areas of dermatology, respiratory and oncology.

Glenmark is a leading global innovative pharmaceutical company committed to enriching lives worldwide. Our vision is to discover possibilities and make lives of patients better across the globe by developing cures for unmet medical needs. We have a rich pipeline of innovative molecules in various phases of development which are targeted in areas of oncology, respiratory and dermatology.

Our Generics business spans across multiple geographies with the US being our largest market followed by India. Our effort is to make high quality affordable medication accessible to patients across the world. Through our generics medicines we impact over 100 million patients each year globally. We are also a global supplier of high quality API products and a preferred partner for pharmaceutical companies worldwide.

Our 14,000 employees globally are dedicated towards our goal of enriching lives globally. Our values – Achievement, Respect and Knowledge bind our workforce together and consistently fuel our growth. At Glenmark, we have created a culture which allows our talent to deliver their best and create positive outcomes for themselves, the organization and the community at large.

Through Glenmark Foundation, our CSR activities are largely focused in the areas of Child Health and over the years we have impacted over 900,000 lives globally.

For more information, log onto www.glenmarkpharma.com.

Glenmark Pharmaceuticals stand with [A new way for a new world.]

Company Website: http://www.glenmarkpharma.com/
Company Website2: http://www.glenmarkpharma.com/
LinkedIn page URL: https://in.linkedin.com/company/glenmark-pharmaceuticals
Wiki Profile URL: https://en.wikipedia.org/wiki/Glenmark_Pharmaceuticals

Popular Search Keywords: glenmark pharmaceuticals limited , company management , company history , company profile , company information , business directory , Stock Market News , annual report , quarterly results , profit and loss , Koo Capital , KooCapital.Com , KooCapital News , Health Technology Sector Company , Pharmaceuticals: Other industry

#glenmark #pharmaceuticals #limited #company #management #company #history #company #profile #company #information #business #directory #stock #market #news #annual #report #quarterly #results #profit #and #loss #koo #capital #koocapital #com #koocapital #news #health #technology #sector #company #pharmaceuticals #other #industry

The post Glenmark Pharmaceuticals Limited – Company Profile – Company information | KooCapital.Com appeared first on KooCapital.Com.

Ajanta Pharma Limited is a holding company, which engages in the development, manufacture, and marketing of pharmaceutical products. The firm offers branded generics and generics that serve a range of therapeutic segments such as antibiotic, anti-malarial, anti-diabetic, cardiology, gynecology, orthopedics, pediatric, respiratory, and general health. It operates through the following geographical segments: India, Africa, Asia, USA, and Others. The company was founded by Purushottam Bhagwand Agrawal in 1973 and is headquartered in Mumbai, India.

ajanta pharma limited company operating in Health Technology Sector and dealing in Pharmaceuticals: Other. ajanta pharma limited is SEBI Listed Company (India) and having:-

ISIN (An International Securities Identification Number): INE031B01049
Equity Stock (National Stock Exchange) Symbol: AJANTPHARM
NSE Link IS: https://www.nseindia.com/get-quotes/equity?symbol=AJANTPHARM
BSE Link IS: https://www.bseindia.com/stock-share-price/ajanta-pharma-ltd/AJANTPHARM/532331/

Ajanta Pharma is primarily engaged in development, manufacturing and marketing of speciality pharmaceutical quality finished dosages.(Source : 202003-01 Annual Report Page No:70)

India – Branded Generic business (30% of revenues) Focused on niche and first-to-market drugs in 4 therapeutic areas – cardiology, ophthalmology, dermatology, pain management

Ajanta Pharma Limited (APL) is a pharmaceutical company headquartered in Mumbai, India. It has strong presence in Branded Generic business in India & Emerging markets; and Generic business in USA.

In India, company operates in selected therapeutic areas of Cardiology, Dermatology, Ophthalmology and Pain management. It’s brands hold leadership positions in sub-therapeutic areas they are present in.

In Emerging Markets, company has presences in Africa, South East Asia, West Asia, and CIS on broader therapeutic segments such as anti-malarial, gastro, antibiotics, cardiology, dermatology, pain management, etc.

As on 31 March 2021, Ajanta has 36 ANDA approvals which are commercialised. And it is awaiting US FDA approval for 15 ANDAs. Company plans to file 10-12 ANDAs during the current financial year.

Company has state-of-the-art research facilities for formulation and API development located at Mumbai, India. R&D capabilities are evident from number of 1st to market products launched by the company providing patients most needed compliance and convenience. A dedicated and focused team of over 650+ scientists work for R&D, which is growing continuously.

Ajanta has 6 formulations manufacturing facilities located in India and 1 in Mauritius. Besides that, it also has an API manufacturing facility located at Waluj, India. Ajanta’s flagship formulation facilities at Paithan (Maharashtra, India) and Dahej (Gujarat, India) have been approved by US FDA.

Ajanta continuously invests in enhancing the existing manufacturing facilities to meet current cGMP requirements and also construct new facilities to meet company’s growth requirements.

Please visit http://ajantapharma.com/ for more information.

Ajanta Pharma Ltd stand with [Serving Health Care Needs Worldwide]

Company Website: http://www.ajantapharma.com/
Company Website2: http://www.ajantapharma.com/
LinkedIn page URL: https://in.linkedin.com/company/ajanta-pharma-ltd
Wiki Profile URL: https://en.wikipedia.org/wiki/Ajanta_Pharma

Popular Search Keywords: ajanta pharma limited , company management , company history , company profile , company information , business directory , Stock Market News , annual report , quarterly results , profit and loss , Koo Capital , KooCapital.Com , KooCapital News , Health Technology Sector Company , Pharmaceuticals: Other industry

#ajanta #pharma #limited #company #management #company #history #company #profile #company #information #business #directory #stock #market #news #annual #report #quarterly #results #profit #and #loss #koo #capital #koocapital #com #koocapital #news #health #technology #sector #company #pharmaceuticals #other #industry

The post Ajanta Pharma Limited Company Profile | KooCapital.Com appeared first on KooCapital.Com.

Cadila Healthcare Limited engages in the discovery, development, and manufacture of pharmaceutical products under Zydus brand. The firm’s products portfolio includes active pharmaceutical ingredients, human formulations, and animal health & veterinary. It operates through the following segments: Pharmaceuticals and Consumer Products. The Pharmaceuticals segment represents the business of integrated pharmaceutical operations with business encompassing the entire value chain in the research, development, production, marketing and distribution of pharmaceutical products. The Consumer Products segment represents the business of development, production, marketing, and distribution of differentiated health and wellness products. The company was founded by Ramanbhai B. Patel in 1952 and is headquartered in Ahmedabad, India.

cadila healthcare limited company operating in Health Technology Sector and dealing in Pharmaceuticals: Other. cadila healthcare limited is SEBI Listed Company (India) and having:-

ISIN (An International Securities Identification Number): INE010B01027
Equity Stock (National Stock Exchange) Symbol: CADILAHC
NSE Link IS: https://www.nseindia.com/get-quotes/equity?symbol=CADILAHC
BSE Link IS: https://www.bseindia.com/stock-share-price/cadila-healthcare-ltd/CADILAHC/532321/

In 1995, the group was restructured and thus was formed Cadila Healthcare under the aegis of the Zydus group. From a humble turnover Rs. 250 crores in 1995 the group witnessed a significant financial growth and registered a turnover of over Rs. 14,253 crores in FY20. Adhering to its brand promise of being dedicated to life in all its dimensions, Zydus continues to innovate with an unswerving focus to address the unmet healthcare needs. Simultaneously it rededicates itself to its mission of creating healthier, happier communities across the globe

US Generic business (45% of revenues) Ranked 4th among US generic companies [1], having grown sales from ~$211 mn in FY11 to $828mn in FY20

CADILA HEALTHCARE LTD is a pharmaceuticals company based out of Zydue Tower, AHMEDABAD, India.

CADILA HEALTHCARE LTD stand with []

Company Website: https://onlinecareer360.com/
Company Website2: http://www.zyduscadila.com/
LinkedIn page URL: https://in.linkedin.com/company/cadila-healthcare-ltd
Wiki Profile URL: https://en.wikipedia.org/wiki/Cadila_Healthcare

Popular Search Keywords: cadila healthcare limited , company management , company history , company profile , company information , business directory , Stock Market News , annual report , quarterly results , profit and loss , Koo Capital , KooCapital.Com , KooCapital News , Health Technology Sector Company , Pharmaceuticals: Other industry

#cadila #healthcare #limited #company #management #company #history #company #profile #company #information #business #directory #stock #market #news #annual #report #quarterly #results #profit #and #loss #koo #capital #koocapital #com #koocapital #news #health #technology #sector #company #pharmaceuticals #other #industry

The post Cadila Healthcare Limited – Company Profile – Company information | KooCapital.Com appeared first on KooCapital.Com.

Aurobindo Pharma Limited engages in the manufacturing of generic pharmaceuticals and active pharmaceutical ingredients. Its portfolio includes antibiotics, anti-retrovirals, cardiovascular, central nervous system, gastroenterological, anti-allergies, and anti-diabetics. The company was founded by Penaka Venkata Ramprasad Reddy and Kambam Nithyananda Reddy on December 26, 1986 and is headquartered in Hyderabad, India.

aurobindo pharma limited company operating in Health Technology Sector and dealing in Pharmaceuticals: Other. aurobindo pharma limited is SEBI Listed Company (India) and having:-

ISIN (An International Securities Identification Number): INE406A01037
Equity Stock (National Stock Exchange) Symbol: AUROPHARMA
NSE Link IS: https://www.nseindia.com/get-quotes/equity?symbol=AUROPHARMA
BSE Link IS: https://www.bseindia.com/stock-share-price/aurobindo-pharma-ltd/AUROPHARMA/524804/

Aurobindo Pharma is principally engaged in manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services.(Source : 202003 Annual Report Page No:159)

Founded in 1986 by Mr. P. V. Ramprasad Reddy, Mr. K. Nithyananda Reddy and a small group of highly committed professionals, Aurobindo Pharma was born of a vision. The company commenced operations in 1988-89 with a single unit manufacturing Semi-Synthetic Penicillin (SSP) at Pondicherry.

Aurobindo Pharma became a public company in 1992 and listed its shares on the Indian stock exchanges in 1995. In addition to being the market leader in Semi-Synthetic Penicillins, it has a presence in key therapeutic segments such as neurosciences, cardiovascular, anti-retrovirals, anti-diabetics, gastroenterology and anti-biotics, among others.

AUROBINDO PHARMA LTD stand with slogan [Committed to healthier life!]

Company Website: https://www.aurobindo.com/
Company Website2: http://www.aurobindo.com/
LinkedIn page URL: https://in.linkedin.com/company/aurobindopharma
Wiki Profile URL: https://en.wikipedia.org/wiki/Aurobindo_Pharma

Popular Search Keywords: aurobindo pharma limited, company management, company history, company profile, company information, business directory,Stock Market News, annual report, quarterly results, profit and loss, Koo Capital, KooCapital.Com, KooCapital News, Health Technology Sector Company, Pharmaceuticals: Other industry

#aurobindo #pharma #limited #company #management #company #history #company #profile #company #information #business #directory #stock #market #news #annual #report #quarterly #results #profit #and #loss #koo #capital #koocapital #com #koocapital #news #health #technology #sector #company #pharmaceuticals #other #industry

The post Aurobindo Pharma Limited – Company Profile – Company information | KooCapital.Com appeared first on KooCapital.Com.